January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 28, 2025
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kidney disease, heart failure, and the use of RAAS inhibitors, increasing the need for effective potass...
November 27, 2025
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North America led the global market owing to a strong R&D pipeline & biopharmaceutical innovations in ...
November 24, 2025
Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for pharmaceuticals rises amid chronic conditions & rare diseases. North America’s dominance c...
November 20, 2025
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects of cancer medications and treatments fuels the demand for cancer supportive care drugs. North Ameri...
November 20, 2025
According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as well as lipid-lowering drug innovations. North America led the market due to the high healthcare invest...
November 17, 2025
Market insights predict the U.S. pharmaceutical industry will increase from USD 520.4 billion in 2025 to USD 965 billion by 2035, achieving a CAGR of 6.37%. The strong presence of pharmaceutical companies and favorable regulatory support bolsters market growth....
November 13, 2025
According to market projections, the small molecule API sector is expected to grow from USD 206.9 billion in 2025 to USD 374.03 billion by 2035, reflecting a CAGR of 6.1%. The small molecule API market is growing due to rising investment by key players. North America’s dominance is attributed to the rising collaboration among the key players....
November 06, 2025
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expanding due to the growing availability of affordable generic alternatives and technological innovations. ...
November 06, 2025
Market insights predict, the dengue vaccine industry is expected to grow from USD 751.01 million in 2025 to USD 2297.33 million by 2035, driven by a CAGR of 11.74%. The dengue vaccine market is growing due to a rise in government initiatives to promote dengue vaccination campaigns. North America dominates the market due to a strong presence of the ...
November 05, 2025
Market insights predict, the branded generics industry is expected to grow from USD 383.1 billion in 2025 to USD 867.21 billion by 2035, driven by a CAGR of 8.47%. The branded generics market is growing due to the rising prevalence of chronic health conditions has increased demand for long-term drug therapies. North America is leading due to the st...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com